We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Peter E. Baker
Peter E. Baker
Products
PRODUCTS
Ningxia Qiyuan Pharmaceutical Co., Ltd.
Peter E. Baker
and
Uttaniti Limchumroon
Price:
$117.00
View
Novacyl Wuxi Pharmaceutical Co., Ltd.
Peter E. Baker
and
Anh Lac
Price:
$117.00
View
Yunnan Hande Bio-Tech Co., Ltd.
Peter E. Baker
and
Guang Gao
Price:
$117.00
View
Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Peter E. Baker
and
Lindsey M. Schwierjohann
Price:
$117.00
View
Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Peter E. Baker
and
Christopher T. Middendorf
Price:
$117.00
View
Ipca Laboratories Ltd.
Peter E. Baker
and
Joanne E. King
Price:
$117.00
View
Chifeng Pharmaceutical Co., Ltd.
Peter E. Baker
Price:
$117.00
View
Chongqing Pharmaceutical Research Institute Co., Ltd.
Peter E. Baker
and
Marijo B. Kambere
Price:
$117.00
View
BrightGene Bio-Medical Technology
Peter E. Baker
,
Thomas J. Cosgrove
, and
Guang Gao
Price:
$117.00
View
Shanghai Desano Chemical Pharmaceutical Co., Ltd.
Peter E. Baker
Price:
$117.00
View
View All Products by Peter E. Baker
Upcoming Events
07
May
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
14
May
2024 Avoca Quality Consortium Summit
23
May
Maximizing Trial Success Requires Evolving Feasibility and Recruitment Strategies
30
May
FDA Oversight of Laboratory-Developed Tests — The Impact of the Final Rule
20
Jun
Inspection Readiness for EU GMP Annex 1 – Manufacture of Sterile Medicinal Products
21
Oct
MAGI@home Clinical Research Conference 2024
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
Quality Observations in Form 483 Earn Maryland Company Warning Letter as Well
GAO Report Criticizes HHS Emergency Stockpile Management, Offers Recommendations
FDA’s Cavazzoni Says AdComms Returning to In Person Soon
UK’s MHRA Unveils Plans for AI as a Medical Device
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More